NLRP3 and inflammatory bowel disease: As NLRP3 is a core component of the inflammatory response, if the relationship between NLRP3 and intestinal microbes and inflammation-related factors can be analyzed for its related inflammatory signaling pathways, its expression status and specific mechanisms in the course of IBD can be elucidated and further considered for clinical diagnosis and treatment of UC, it is expected that lead compounds targeting NLRP3 inflammasome can be developed to treat UC.